Arterial Blood Gas (ABG) Machine Market Size, Share & Trends Analysis Report By Type (Bench top, Portable), By Application (Cardiovascular surgeries, Anesthesiology, ICU) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Market Overview

The global arterial blood gas machine market size was valued at USD 1.49 billion in 2025 and is projected to grow from USD 1.60 billion in 2026 to USD 2.81 billion by 2034, registering a CAGR of 7.29% during the forecast period from 2026 to 2034. North America dominated the arterial blood gas machine market with a market share of 38.2% in 2025.

Blood gas analyzers are used in the diagnosis of several physiological parameters, such as blood vessel hemorrhage, diabetes, drug overdose, and shock testing, including hydrogen ion concentration, electrolytes, and oxygen concentration. Blood gas levels provide accurate results for acid-base balance, blood gases, and other electrolyte balance. ABG is helpful in the diagnosis of a variety of metabolic acid/base disorders, ventilation complications, and hypoxemia in the intensive care unit. Following the onset of therapy, repeat ABG may assess the efficacy of the intervention (e.g., when mechanical ventilation is performed for respiratory failure) and also indicate the degree of respiratory and renal compensation for a given acid/base condition.

ABGs are particularly helpful in operating theatre where acid/base status can dynamically change during cardiopulmonary bypass, one-lung ventilation, transplant surgery, and urological procedures. Its analysis is also helpful where tight control of partial CO2 pressure is necessary for better patient outcomes; for example, in neurosurgical cases where the impact of carbon dioxide on intracranial pressure (ICP) may be crucial. Additionally, blood gas testing is often recommended for patients assisted by the ventilator, undergoing respiratory distress evaluation to offer insights on the patient's oxygen level.

Segmental Analysis

Portable Blood Gas Machines Segment to Dominate the Market

The portable blood gas machines segment held the largest market share in 2018 and is projected to dominate the market during the forecast period on account of its ability to render instantaneous test results and faster turnaround time. The segment’s primary driver is the increasing demand for point-of-care blood gas machines.

Request Customizationto receive a tailored report.

Umpteen Benefits Offered by Bench Top Abg to Drive the Segment Growth

The benchtop ABG segment leads the market on account of its increasing applications in umpteen hospital settings. Benchtop analyzers offer a range of benefits such as individual biosensor technology, broad test menu, and low cost of operation, further driving the segment growth.

Increasing Demand for Abg Machines in Icu’s

The ICU segment holds the highest market share during the forecast period owing to the increasing number of patients admitted in intensive care units and emergency wards. Increasing demand of ABG machine to track the pH levels, carbon dioxide, and oxygen in the blood and determine the occurrence of medical conditions such as heart failure, kidney failure, chemical poisoning, drug overdose, and hemorrhage drives the segment growth.

Speak to an Analystto discuss market opportunities.

Regional Analysis

Strong Presence of Domestic and International Players to Drive North America’s Market Growth

North America dominates the arterial blood gas machines market as the region is backed by the presence of umpteen healthcare practitioners. Increasing patient awareness, availability of well-established healthcare infrastructure, and government support drive the regional market growth. As per the Centers for Disease Control and Prevention (CDC) report, in the U.S., around 1.7 million emergency department visits were recorded in 2017. The strong presence of domestic and international medical device manufacturers supplying ABG machines to both the developed and emerging markets provides an impetus to the regional market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Rapid Product Development by Prominent Players to Drive Europe’s Market Growth

Europe’s arterial blood gas machines market is backed by the presence of prominent medical device companies and the growing geriatric population. Apart from this, increasing prevalence of cancer and other chronic disorders, rising public funding in healthcare, and favorable government initiatives provide an impetus to the market growth. Recently, Siemens Healthineers, a German-based medical device company, launched RAPID Point 500e Blood Gas Analyzer, a trusted instrument in Europe's endeavor, to combat COVID-19 and help address unprecedented demand for blood gas testing.

List of Key and Emerging Players in Arterial Blood Gas (ABG) Machine Market